Ketamine Therapy for PTSD in Silicon Valley: An Evidence-Based Overview

Understanding PTSD and the Need for Individualized Care

Post-traumatic stress disorder is often described as a disorder of memory—not because patients are imagining their trauma, but because the brain’s threat-processing systems can remain activated long after a traumatic event has passed. PTSD may involve intrusive memories, avoidance, hyperarousal, and persistent distress that affects work, relationships, and daily life (National Center for PTSD, n.d.).

Evidence-based PTSD care commonly includes trauma-focused psychotherapy, such as cognitive processing therapy, eye movement desensitization and reprocessing, or prolonged exposure, as well as selected medications when appropriate (U.S. Department of Veterans Affairs & U.S. Department of Defense, 2023). Still, some people continue to experience substantial symptoms despite prior treatment. If you’re wondering what PTSD really is and how it is diagnosed, our overview covers the fundamentals.

At Soft Reboot Wellness in Menlo Park, we offer IV ketamine therapy as an off-label option for PTSD. For Bay Area patients considering this approach, it is important to understand both the emerging research and its limitations.

What the Research Says About Ketamine for PTSD

The research base for ketamine in PTSD remains limited and mixed, though several studies have reported rapid reductions in PTSD symptom severity following IV ketamine infusion.

A randomized clinical trial of a single IV infusion found lower PTSD symptom severity 24 hours after treatment compared with an active placebo (Feder et al., 2014). A later randomized controlled trial of repeated infusions also found greater short-term improvement in PTSD symptom severity in the ketamine group than in the control group, but the study included only 30 participants and called for further research (Feder et al., 2021).

Recent systematic reviews and meta-analyses suggest ketamine may have potential for PTSD, while emphasizing heterogeneity across studies, limited sample sizes, and uncertainty around long-term outcomes (Almeida et al., 2024; Sicignano et al., 2024).

Ketamine acts on the NMDA receptor and glutamate system. Researchers are studying whether its effects on glutamate signaling, neuroplasticity, and memory processing may help explain observed changes in some PTSD symptoms. These proposed mechanisms remain under investigation and should not be treated as established explanations for every patient response (Abdallah et al., 2016). For a deeper look at the neuroscience involved, our educational ketamine science page provides an accessible overview.

Important Limits of the Current Evidence

It is critical to be precise about what the evidence supports and where its limits lie. IV ketamine for PTSD is off-label. It is not FDA-approved for PTSD or other psychiatric conditions; ketamine itself is FDA-approved as an anesthetic (National Institute on Drug Abuse, 2024).

The current 2023 VA/DoD Clinical Practice Guideline suggests against ketamine as a primary treatment for PTSD because available research has not yet established clear enough benefit relative to its risks and side-effect burden. The same guideline recommends trauma-focused psychotherapies over medication interventions for PTSD treatment (U.S. Department of Veterans Affairs & U.S. Department of Defense, 2023).

This does not make an individualized consultation meaningless. It does mean that careful clinical selection, informed consent, and honest discussion of realistic outcomes are essential.

At Soft Reboot Wellness, Dr. Sara Herman, MD conducts a detailed intake evaluation that includes PTSD symptoms, treatment history, current medications, and relevant medical and psychiatric factors before making any recommendation.

PTSD in High-Pressure Professional Environments

The profile of people seeking PTSD care in the Bay Area is diverse. Some are professionals in technology, finance, healthcare, or other high-pressure fields who have lived with symptoms for years while continuing to meet demanding responsibilities. Others are veterans, first responders, or people whose trauma symptoms have not responded adequately to prior therapy or medication.

High-functioning does not mean unaffected. Many people manage PTSD symptoms privately for a long time before seeking additional support. Understanding how ketamine infusion therapy is helping patients with PTSD can be a useful first step for those who are still weighing their options.

What IV Ketamine Treatment May Involve

Ketamine therapy for PTSD at Soft Reboot Wellness is not a quick fix, and treatment plans are individualized from the beginning.

A standard initial protocol involves four to six IV infusions over four to six weeks, with the number and timing adjusted according to clinical response. Dr. Herman personally administers and monitors infusion sessions, including vital-sign monitoring throughout treatment.

During an infusion, patients may experience dissociation, altered perception of time, or dreamlike imagery. These effects are temporary and generally resolve before discharge. Patients need a ride home after each session.

Our team prepares patients for what to expect during ketamine therapy before the first appointment, including practical questions about the treatment environment, recovery period, and post-session planning.

Ketamine, Psychotherapy, and Ongoing Care

A common question is whether ketamine therapy can be combined with psychotherapy for PTSD. This remains an area of active research and clinical interest.

Some patients choose to continue working with an existing psychologist, trauma therapist, or psychiatrist while considering ketamine treatment. Soft Reboot Wellness can coordinate care with outside providers when appropriate and with patient consent.

Ketamine should not be presented as a replacement for established trauma-focused care. Treatment decisions should consider the full clinical picture, including prior treatment, current supports, medical history, and individual goals.

For a broader overview of the medication’s proposed effects and treatment process, see what ketamine therapy actually does.

Considering Stellate Ganglion Block for PTSD

Soft Reboot Wellness also offers Stellate Ganglion Block (SGB) as a separate option that may be discussed for patients experiencing PTSD-related hyperarousal or sympathetic nervous system dysregulation.

SGB is not interchangeable with ketamine therapy, and not every patient is a candidate for either treatment. Current VA/DoD guidance finds insufficient evidence to recommend for or against SGB for PTSD, so candidacy and expectations should be discussed carefully during consultation (U.S. Department of Veterans Affairs & U.S. Department of Defense, 2023).

Patients interested in learning more can review our overview of Stellate Ganglion Block for PTSD.

Schedule, Cost, and Practical Considerations

Two practical barriers are worth addressing directly.

The first is schedule. An initial infusion series requires time for appointments, recovery, and follow-up planning. Soft Reboot Wellness works to offer appointment availability that accommodates demanding professional schedules.

The second is cost. IV ketamine therapy for PTSD is off-label, and insurance coverage is not standard. We discuss pricing transparently during consultation so patients can make informed financial decisions.

Results vary by individual, and we do not make promises about PTSD outcomes. Our role is to provide physician-led care, transparent evidence communication, and individualized assessment for patients exploring their options.

FAQ

Is ketamine therapy for PTSD covered by insurance?
Insurance coverage for IV ketamine therapy for PTSD is not standard and varies by plan. Our team discusses fees and practical considerations during consultation so you can make an informed decision.

What PTSD symptoms does ketamine specifically target?
Clinical studies generally assess changes in overall PTSD symptom severity. Research has not established that ketamine will improve any specific symptom for every patient. Individual responses can vary.

Can I continue my current PTSD medications during ketamine therapy?
Do not stop or change prescribed medications on your own. Dr. Herman reviews your complete medication list during intake and will discuss whether any changes or additional considerations are appropriate before treatment.

How does ketamine for PTSD differ from ketamine for depression?
The infusion process may appear similar, but PTSD and depression involve different symptom patterns and evidence bases. Some people experience both conditions, and treatment planning should account for the full clinical picture rather than treating diagnoses in isolation.

Are there people with PTSD who should not receive IV ketamine therapy?
Yes. Candidacy depends on a person’s medical history, psychiatric history, current medications, trauma history, and other individual factors. A thorough medical and psychiatric review helps determine whether ketamine therapy is appropriate.

Key Takeaways

• IV ketamine for PTSD is off-label and is not FDA-approved for PTSD.
• Small randomized trials and systematic reviews suggest potential short-term symptom improvement, but the evidence remains limited and mixed.
• Current VA/DoD guidance prioritizes trauma-focused psychotherapy for PTSD and suggests against ketamine as a primary PTSD treatment.
• Soft Reboot Wellness offers physician-led IV ketamine therapy under Dr. Sara Herman, MD, with individualized monitoring and candidacy review.
• A typical initial Soft Reboot Wellness protocol involves four to six infusions over four to six weeks, with timing personalized to clinical response.
• Results vary by individual, and coordination with existing mental health providers is encouraged.

Conclusion

PTSD that persists despite standard treatment deserves serious, individualized clinical attention. For some people, a consultation about IV ketamine therapy may be part of exploring the full range of available options—but it should include a clear understanding of current evidence, established PTSD treatments, and the limits of emerging interventions.

At Soft Reboot Wellness in Menlo Park, Dr. Sara Herman provides physician-led evaluation and monitoring for patients considering IV ketamine therapy. To discuss whether a consultation may be appropriate, contact our team today.

References

Abdallah, C. G., Adams, T. G., Kelmendi, B., Esterlis, I., Sanacora, G., & Krystal, J. H. (2016). Ketamine’s mechanism of action: A path to rapid-acting antidepressants. Depression and Anxiety, 33(8), 689–697.

Almeida, T. M., Lacerda da Silva, U. R., Pires, J. P., Borges, I. N., Martins, C. R. M., Cordeiro, Q., & Uchida, R. R. (2024). Effectiveness of ketamine for the treatment of post-traumatic stress disorder: A systematic review and meta-analysis. Clinical Neuropsychiatry, 21(1), 22–31. https://doi.org/10.36131/cnfioritieditore20240102

Feder, A., Parides, M. K., Murrough, J. W., Perez, A. M., Morgan, J. E., Saxena, S., Kirkwood, K., aan het Rot, M., Lapidus, K. A. B., Wan, L.-B., Iosifescu, D., & Charney, D. S. (2014). Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: A randomized clinical trial. JAMA Psychiatry, 71(6), 681–688. https://doi.org/10.1001/jamapsychiatry.2014.1435

Feder, A., Costi, S., Rutter, S. B., Collins, A. B., Govindarajulu, U., Jha, M. K., Horn, S. R., Kautz, M., Corniquel, M., Collins, K. A., Bevilacqua, L., Glasgow, A. M., Brallier, J., Pietrzak, R. H., Murrough, J. W., & Charney, D. S. (2021). A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder. American Journal of Psychiatry, 178(2), 193–202. https://doi.org/10.1176/appi.ajp.2020.20050596

National Center for PTSD. (n.d.). PTSD basics. https://www.ptsd.va.gov/understand/what/ptsd_basics.asp

National Institute on Drug Abuse. (2024, April 9). Ketamine. https://nida.nih.gov/research-topics/ketamine

Sicignano, D. J., Kurschner, R., Weisman, N., Sedensky, A., Hernandez, A. V., & White, C. M. (2024). The impact of ketamine for treatment of post-traumatic stress disorder: A systematic review with meta-analyses. Annals of Pharmacotherapy, 58(7), 715–723.

U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). VA/DoD clinical practice guideline for management of posttraumatic stress disorder and acute stress disorder. https://www.ptsd.va.gov/professional/treat/txessentials/clinician_guide_meds.asp

About Dr. Sara Herman

Dr. Sara Herman, MD, is a Harvard-trained anesthesiologist who founded Soft Reboot Wellness after guiding more than 10,000 patients through anesthesia and ketamine therapy. Her clinical experience in ketamine administration, pharmacology, and patient monitoring shapes each treatment plan, from individualized dosing to physiological monitoring throughout the infusion experience.

At Soft Reboot Wellness, Dr. Herman provides a physician-led approach for patients exploring ketamine therapy, grounded in individualized assessment, informed consent, and evidence-informed care.

Medical Disclaimer

The content provided on this page is for educational purposes only and does not constitute medical advice. IV ketamine therapy for PTSD is used off-label and is not FDA-approved for this indication. Individual results vary, and not every patient is an appropriate candidate. This information should not replace a consultation with a qualified medical provider. Please discuss with your provider whether any treatment described here is appropriate for your specific health situation. Soft Reboot Wellness serves patients in Menlo Park, CA and the greater Bay Area.